Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Cap	50,120	58,706	46,800	43,601	51,237	45,316
Market Cap Growth	7.60%	25.44%	7.34%	-14.90%	13.07%	-20.63%
Enterprise Value	80,454	85,480	74,219	72,475	80,077	73,822
Last Close Price	15.91	18.52	14.87	13.89	16.48	14.32
PE Ratio	41.56	49.10	66.32	46.15	21.67	23.91
PS Ratio	1.77	2.07	1.53	1.55	1.69	1.55
PB Ratio	1.03	1.20	1.01	0.91	1.07	0.97
P/FCF Ratio	9.28	10.76	8.19	12.20	8.13	5.52
P/OCF Ratio	7.65	8.94	6.64	9.22	6.96	4.91
EV/Sales Ratio	2.84	3.01	2.43	2.57	2.64	2.52
EV/EBITDA Ratio	9.50	12.00	10.08	11.65	9.21	8.61
EV/EBIT Ratio	20.46	33.16	32.48	51.26	21.68	19.50
EV/FCF Ratio	14.90	15.66	12.99	20.29	12.71	8.99
Debt / Equity Ratio	0.56	0.56	0.57	0.62	0.64	0.73
Debt / EBITDA Ratio	4.32	4.32	4.09	5.14	3.80	4.16
Debt / FCF Ratio	5.64	5.64	5.27	8.96	5.24	4.35
Net Debt / Equity Ratio	0.55	0.55	0.59	0.60	0.60	0.61
Net Debt / EBITDA Ratio	3.76	3.76	3.72	4.64	3.32	3.32
Net Debt / FCF Ratio	4.91	4.91	4.80	8.08	4.58	3.47
Asset Turnover	0.29	0.30	0.31	0.29	0.30	0.30
Inventory Turnover	1.12	1.20	1.30	1.30	1.35	2.35
Quick Ratio	0.62	0.62	0.45	0.51	0.50	0.75
Current Ratio	1.27	1.27	1.01	1.11	0.97	1.21
Return on Equity (ROE)	2.49%	2.61%	1.52%	2.12%	5.27%	6.31%
Return on Assets (ROA)	1.96%	2.03%	1.44%	4.02%	3.06%	2.92%
Return on Invested Capital (ROIC)	2.10%	2.15%	1.51%	4.22%	3.24%	2.96%
Return on Capital Employed (ROCE)	3.17%	3.30%	2.79%	1.76%	4.36%	4.60%
Earnings Yield	2.41%	2.04%	1.51%	2.17%	4.61%	4.18%
FCF Yield	10.78%	9.30%	12.21%	8.19%	12.30%	18.12%
Dividend Yield	1.58%	3.37%	4.30%	4.36%	4.11%	5.20%
Payout Ratio	33.45%	162.65%	280.28%	199.34%	88.14%	123.30%
Buyback Yield / Dilution	0.16%	0.16%	-1.58%	-0.67%	0.46%	-0.23%
Total Shareholder Return	1.74%	3.53%	2.72%	3.70%	4.58%	4.97%

SEC Filings: 10-K · 10-Q